v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
3 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Income Statement [Abstract]    
Revenues $ 2,776,535 $ 1,748,129
Cost of goods sold 3,259,926 1,573,464
Gross (loss) profit (483,391) 174,665
Operating Expenses    
Research and development 1,626,440 1,353,551
Sales and marketing 2,041,511 1,288,760
General and administrative 3,483,095 2,863,758
Impairment loss 93,050
Total operating expenses 7,244,096 5,506,069
Operating loss (7,727,487) (5,331,404)
Other (income) expense    
Loss on sale of equity method investment 4,008,357
Equity method loss 734,143
Investment loss, net 239,490
Interest (income) expense, net (24,554) 21,857
Other, net (29,057) 1,544
Other expense 4,688,889 262,891
Net loss from continuing operations (12,416,376) (5,594,295)
Loss from discontinued operations (242,573)
Net loss (12,416,376) (5,836,868)
Other comprehensive income (loss)    
Change in foreign currency translation adjustments (4,621) 1,646
Unrealized gain on marketable securities 289,389
Other comprehensive loss  $ (12,420,997) $ (5,545,833)
Loss per share - basic and diluted    
Continuing operations $ (0.17) $ (0.11)
Discontinued operations
Weighted average shares outstanding - basic and diluted 74,500,480 54,935,339

Source